stella
beta
Treatment of Moderate to Severe Refractory Crohn's Disease — Stella
Recruiting
Back to Crohns Disease trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(13 sites)
United States
Mayo Clinic Arizona, Scottsdale, Arizona
University of California, Davis, Sacramento, California
University of California, San Francisco, San Francisco, California
University of Florida, Gainesville, Florida
Northwestern, Chicago, Illinois
Show all 13 locations
View full record on ClinicalTrials.gov